Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

NCT03699618 · clinicaltrials.gov ↗

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Challenging Enrollment

Conditions

Submacular Hemorrhage
Wet Macular Degeneration
Neovascular Age-related Macular Degeneration

Interventions

DRUG: Anti-VEGF
OTHER: Hemorrhage displacement + Anti-VEGF

Sponsor

Johns Hopkins University